Epilepsy Monitoring Devices Market - Top Companies and Manufacturers

Companies Dominating the Epilepsy Monitoring Devices Landscape

Natus Medical Incorporated
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Compumedics Limited
Empatica Inc.
Magstim, Inc.
Nihon Kohden Corporation
Medtronic Plc
Boston Scientific Corporation
Masimo Corporation
Drägerwerk AG & Co. KGaA
Abbott Laboratories

Browse Key Market Insights with Data Illustration:

Epilepsy Monitoring Devices Market | Growth Drivers, 2023-2035

In the News

Empatica Inc. has obtained Food and Drug Administration (FDA) approval for Embrace2, which employs AI (advanced machine learning) in a wristwatch. It uses Electrodermal Activity (EDA), a signal that stress researchers employ to measure physiological changes associated with sympathetic nervous system activity.
Magstim, Inc. developed ‘Horizon 3.0’, which has received clearance from the FDA (Food and Drug Administration) as a transcranial magnetic stimulation platform. It offers improved workflows with guided transcranial magnetic stimulation (TMS), and analytics for the therapeutic context.

Frequently Asked Questions (FAQ)

An increase in brain Injuries and a rising geriatric population are the major factors driving the market growth.

The market is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2023-2035.

Exorbitant price of advanced epilepsy monitoring equipment and low awareness among people in low and middle-income countries for these medical devices are estimated to be the growth hindering factors for the market expansion.

The market in the Europe region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Compumedics Limited, Empatica Inc., Magstim, Inc., Nihon Kohden Corporation, Medtronic Plc, Boston Scientific Corporation, Masimo Corporation, DrÃ¤gerwerk AG & Co. KGaA, Abbott Laboratories, and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product, technology, epilepsy detection & prediction devices, end user, and by region.

The deep brain stimulations segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

Epilepsy Monitoring Devices Market - Top Companies and Manufacturers

Companies Dominating the Epilepsy Monitoring Devices Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What are the major factors driving the growth of the epilepsy monitoring devices market?

What would be the CAGR of epilepsy monitoring devices market over the forecast period?

What are the challenges affecting the epilepsy monitoring devices market growth?

Which region will provide more business opportunities for growth of epilepsy monitoring devices market in future?

Who are the major players dominating the epilepsy monitoring devices market?

How are the company profiles selected?

What are the segments in the epilepsy monitoring devices market?

Which segment captures the largest market size in end-user in the epilepsy monitoring devices market?